Skip to content

CORMEDIX INC.: 10-Q filed 2019-08-14

What CORMEDIX INC. reported in its quarterly report filed 2019-08-14 (fiscal Q2 2019): 37 published measures, 105 facts as tagged in accession 0001654954-19-009628.

This filing

Form
10-Q (quarterly report)
Filed
2019-08-14
Fiscal period
fiscal Q2 2019
Accession
0001654954-19-009628 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORMEDIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-06-3027,559,206USD
At 2018-12-3118,825,914USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-06-3011,084,155USD
At 2018-12-3113,891,658USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-3016,475,051USD
At 2019-03-3116,541,965USD
At 2018-12-314,934,256USD
At 2018-06-30-6,478,017USD
At 2018-03-31840,692USD
At 2017-12-317,193,351USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-06-3014,561,830USD
At 2018-12-3117,623,770USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-696,158USD91
2019-01-01 to 2019-06-30-5,864,042USD181
2019-01-01 to 2019-03-31-5,167,884USD90
2018-04-01 to 2018-06-30-8,556,911USD91
2018-01-01 to 2018-06-30-18,742,029USD181
2018-01-01 to 2018-03-31-10,185,118USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-7,203,015USD181
2018-01-01 to 2018-06-30-11,389,784USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-06-3022,725USD181
2018-01-01 to 2018-06-3038,225USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-04-01 to 2019-06-3035,266USD91
2019-01-01 to 2019-06-30198,958USD181
2018-04-01 to 2018-06-307,551USD91
2018-01-01 to 2018-06-3030,760USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-06-3015,981,357USD181
2018-01-01 to 2018-06-304,149,713USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-11,839,528USD181
2018-01-01 to 2018-06-301,565,973USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-184,852,140USD
At 2018-12-31-178,988,098USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-5,060,778USD91
2019-01-01 to 2019-06-30-5,060,778USD181
2018-04-01 to 2018-06-300USD91
2018-01-01 to 2018-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-06-30146,601USD
At 2018-12-31160,860USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-06-301,415,662USD181
2018-01-01 to 2018-06-30731,468USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-5,537,356USD91
2019-01-01 to 2019-06-30-10,460,537USD181
2018-04-01 to 2018-06-30-8,572,150USD91
2018-01-01 to 2018-06-30-18,760,973USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-06-3027,412,605USD
At 2018-12-3118,665,054USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-04-01 to 2019-06-30306,736USD91
2019-01-01 to 2019-06-30608,783USD181
2018-04-01 to 2018-06-300USD91
2018-01-01 to 2018-06-301,873USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-304,346,456USD
At 2018-12-317,766,230USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-06-30906,084USD
At 2018-12-312,588,977USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-04-01 to 2019-06-305,551,494USD91
2019-01-01 to 2019-06-3010,411,412USD181
2018-04-01 to 2018-06-308,546,038USD91
2018-01-01 to 2018-06-3018,729,495USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-06-30402,714USD
At 2018-12-31428,515USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-3014,138USD91
2019-01-01 to 2019-06-30-49,125USD181
2018-04-01 to 2018-06-30-26,112USD91
2018-01-01 to 2018-06-30-31,478USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-04-01 to 2019-06-3021,128USD91
2019-01-01 to 2019-06-30248,083USD181
2018-04-01 to 2018-06-3033,663USD91
2018-01-01 to 2018-06-3062,238USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-04-01 to 2019-06-302,571,587USD91
2019-01-01 to 2019-06-304,556,509USD181
2018-04-01 to 2018-06-301,945,825USD91
2018-01-01 to 2018-06-303,848,838USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-04-01 to 2019-06-302,979,907USD91
2019-01-01 to 2019-06-305,854,903USD181
2018-04-01 to 2018-06-306,600,213USD91
2018-01-01 to 2018-06-3014,880,657USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-3023,820,334shares
At 2018-12-3121,775,173shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2019-06-3014,733,383USD
At 2018-12-3117,795,323USD
At 2018-06-304,873,531USD
At 2017-12-3110,551,282USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-06-30104,340USD
At 2018-12-3196,522USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-06-304,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-06-303,433,754USD
At 2018-12-315,166,224USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-06-30203,155USD
At 2018-12-31422,199USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-5,756,936USD91
2019-01-01 to 2019-06-30-10,924,820USD181
2018-04-01 to 2018-06-30-8,556,911USD91
2018-01-01 to 2018-06-30-18,742,029USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-687,027USD91
2019-01-01 to 2019-06-30-5,856,224USD181
2018-04-01 to 2018-06-30-8,556,516USD91
2018-01-01 to 2018-06-30-18,743,059USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-06-3040,470USD181
2018-01-01 to 2018-06-3038,734USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-10,728USD181
2018-01-01 to 2018-06-30-61,220USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-25,801USD181
2018-01-01 to 2018-06-3078,743USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-1,682,752USD181
2018-01-01 to 2018-06-305,498,465USD181

Inspect the source

Entity
CORMEDIX INC. / CIK 0001410098
Captured
2026-09-20T08:01:45.168Z
SEC response SHA-256
b75757faacc84388fbe591a3ec2593969ffefe3c9ea86056a188a6fcb0c2f8bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001410098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))